EDOC vs. CANC

Last updated Apr 1, 2026

Compare and contrast key facts about Global X Telemedicine & Digital Health ETF (EDOC) and Tema Oncology ETF (CANC).

EDOC and CANC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. EDOC is a passively managed fund by Global X that tracks the performance of the Solactive Telemedicine & Digital Health Index- TR Net. It was launched on Jul 29, 2020. CANC is an actively managed fund by Tema. It was launched on Aug 14, 2023.

Performance

EDOC vs. CANC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Global X Telemedicine & Digital Health ETF (EDOC) and Tema Oncology ETF (CANC). The values are adjusted to include any dividend payments, if applicable.

EDOC vs. CANC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
EDOC Global X Telemedicine & Digital Health ETF	-18.45%	-0.62%	-2.87%	-12.61%	-29.99%	-6.66%
CANC Tema Oncology ETF	5.69%	42.92%	-5.37%	510.51%	-85.34%	-51.82%

Returns By Period

In the year-to-date period, EDOC achieves a -18.45% return, which is significantly lower than CANC's 5.69% return.

EDOC

• 1D: 2.83%
• 1M: -10.48%
• YTD: -18.45%
• 6M: -25.27%
• 1Y: -15.69%
• 3Y*: -12.07%
• 5Y*: -16.45%
• 10Y*: —

CANC

• 1D: 4.66%
• 1M: -2.88%
• YTD: 5.69%
• 6M: 27.93%
• 1Y: 52.46%
• 3Y*: 140.00%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

EDOC vs. CANC - Expense Ratio Comparison

EDOC has a 0.68% expense ratio, which is lower than CANC's 0.75% expense ratio.

CANC

Tema Oncology ETF

EDOC

Global X Telemedicine & Digital Health ETF

Return for Risk

EDOC vs. CANC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EDOC

EDOC Risk / Return Rank: 3
EDOC Sharpe Ratio Rank: 3
EDOC Sortino Ratio Rank: 2
EDOC Omega Ratio Rank: 3
EDOC Calmar Ratio Rank: 4
EDOC Martin Ratio Rank: 2

CANC

CANC Risk / Return Rank: 90
CANC Sharpe Ratio Rank: 89
CANC Sortino Ratio Rank: 90
CANC Omega Ratio Rank: 82
CANC Calmar Ratio Rank: 94
CANC Martin Ratio Rank: 93

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EDOC vs. CANC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X Telemedicine & Digital Health ETF (EDOC) and Tema Oncology ETF (CANC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	EDOC	CANC	Difference
Sharpe ratio Return per unit of total volatility	-0.64	1.94	-2.58
Sortino ratio Return per unit of downside risk	-0.81	2.59	-3.40
Omega ratio Gain probability vs. loss probability	0.91	1.32	-0.42
Calmar ratio Return relative to maximum drawdown	-0.49	3.86	-4.35
Martin ratio Return relative to average drawdown	-1.38	13.76	-15.14
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

EDOC vs. CANC - Sharpe Ratio Comparison

The current EDOC Sharpe Ratio is -0.64, which is lower than the CANC Sharpe Ratio of 1.94. The chart below compares the historical Sharpe Ratios of EDOC and CANC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	EDOC	CANC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.64	1.94	-2.58
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.63	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.42	-0.04	-0.39

Correlation

The correlation between EDOC and CANC is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

EDOC vs. CANC - Dividend Comparison

EDOC's dividend yield for the trailing twelve months is around 0.40%, more than CANC's 0.05% yield.

	TTM	2025	2024	2023	2022	2021	2020
EDOC Global X Telemedicine & Digital Health ETF	0.40%	0.33%	0.00%	0.00%	0.00%	0.00%	0.03%
CANC Tema Oncology ETF	0.05%	0.06%	3.00%	0.56%	0.00%	0.00%	0.00%

Drawdowns

EDOC vs. CANC - Drawdown Comparison

The maximum EDOC drawdown since its inception was -65.76%, smaller than the maximum CANC drawdown of -97.53%. Use the drawdown chart below to compare losses from any high point for EDOC and CANC.

Drawdown Indicators

	EDOC	CANC	Difference
Max Drawdown Largest peak-to-trough decline	-65.76%	-97.53%	+31.77%
Max Drawdown (1Y) Largest decline over 1 year	-30.71%	-12.40%	-18.31%
Max Drawdown (5Y) Largest decline over 5 years	-61.76%	—	—
Current Drawdown Current decline from peak	-64.79%	-56.19%	-8.60%
Average Drawdown Average peak-to-trough decline	-42.40%	-73.91%	+31.51%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.89%	3.61%	+7.28%

Volatility

EDOC vs. CANC - Volatility Comparison

The current volatility for Global X Telemedicine & Digital Health ETF (EDOC) is 7.53%, while Tema Oncology ETF (CANC) has a volatility of 8.36%. This indicates that EDOC experiences smaller price fluctuations and is considered to be less risky than CANC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	EDOC	CANC	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.53%	8.36%	-0.83%
Volatility (6M) Calculated over the trailing 6-month period	16.50%	16.34%	+0.16%
Volatility (1Y) Calculated over the trailing 1-year period	24.65%	27.24%	-2.59%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.35%	285.66%	-259.31%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	26.33%	285.66%	-259.33%